Dementia Family CaregiverNCT07742189
Medication Collaboration Feasibility Study
A study testing Medication Collaboration Intervention in people with Dementia Family Caregiver and Dementia, run by Northwestern University at 1 site in United States.
Trial summary
This study examines the feasibility and acceptability of a brief medication collaboration intervention among older adults (age 60+) with early-stage dementia or mild cognitive impairment who take multiple medications and their family caregivers. Read more about this study
- Who is it for?
- Ages 60 years and older
- Conditions the study is for
- Dementia Family Caregiver, Dementia, Medication Adherence
- What is being tested?
- Medication Collaboration Intervention
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 30 participants
- Where
- 1 siteUnited States
- Study dates
- 3 Aug 2026to Dec 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 60 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Age 60 or older
- Diagnosis of dementia, Alzhimer's Disease or Mild Cognitive Impairment
- Quick Dementia Rating Scale Score 2-12 (inclusive of mild cognitive impairment and mild dementia)
- Taking 3 or more medications
- Involved with managing their medications
- Proficient speaking English
Show all 10Show fewer
- Capacity to provide consent
- Primary family caregiver for the past 3 months
- Age 18 or older
- Proficient speaking English
Who cannot join
- adults unable to consent
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
Northwestern University
Chicago, Illinois, 60611
Dianne Oladejo, 312.503.6452, dianne.oladejo@northwestern.edu
Rachel O'Conor, r-oconor@northwestern.edu
About this study
Official title: Feasibility Study of a Brief Intervention to Support Medication Collaboration Among Older Adults and Family Care Partners
This study examines the feasibility and acceptability of a brief medication collaboration intervention among older adults (age 60+) with early-stage dementia or mild cognitive impairment who take multiple medications and their family caregivers. The main aims are to: 1) determine the feasibility and acceptability of the intervention for older adults with early-stage dementia and their family caregivers, and 2) explore the effects of intervention on medication collaboration, medication adherence, and beliefs about dementia and autonomy.
In this study, participants will: 1) complete a 15-30-minute baseline interview (by Zoom or phone), 2) participate together in a 45-60-minute virtual intervention led by an interventionist that includes:
Read more
Assessment of medication responsibilities and beliefs. Education about dementia and medication management. Cognitive restructuring to address beliefs about independence and caregiver assistance.
Collaborative planning for medication responsibilities and routines; and lastly 3) complete a 15-20-minute one-month follow-up interview (by Zoom or phone) to assess the intervention's acceptability and changes in medication management outcomes.
- Conditions
- Dementia Family Caregiver, Dementia, Medication Adherence
- Being tested
- Medication Collaboration Intervention
- Medical subject headings
- Dementia, Medication Adherence
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Medication Collaboration InterventionBehavioural
A brief virtual behavioral intervention for older adults with early-stage dementia and their family caregivers designed to support collaborative medication management. The intervention includes: (1) assessment of beliefs about dementia, autonomy, and current medication responsibilities; (2) education on dementia progression and medication management; (3) reframing maladaptive beliefs regarding independence and caregiver assistance; and (4) collaborative development of implementation intentions and medication responsibility plans to facilitate medication adherence and the transition of medication management responsibilities. The intervention is delivered remotely via Zoom or telephone in a single 45-60-minute session by trained study interventionists.
| Study group | Role | What they receive |
|---|---|---|
| Medication Collaboration Intervention | Experimental | Participants receive a brief virtual medication collaboration intervention designed to support collaborative medication management among older adults with early-stage dementia and their family caregivers. The intervention includes an assessment of medication responsibilities and beliefs, dementia and medication management education, reframing beliefs about autonomy and caregiver assistance, and collaborative development of medication management plans and action planning by setting implementation intentions. Receives: Behavioral: Medication Collaboration Intervention |
What is being measured
The primary outcome is the main question the study is designed to answer.
Acceptability of the Medication Collaboration Intervention
Participant-reported acceptability of the intervention will be measured using The Acceptability of Intervention Measure, Intervention Appropriateness Measure, and Feasibility of Intervention Measure. Scale values range from 1 to 5 with a higher score indicating greater perceived acceptability of the Medication Collaboration Intervention.
Measured: 1 Month
Secondary outcomes (5)
Medication Collaboration
Self-report of caregiver involvement with medications will be measured using an adapted version of the dyadic relationship scale. Scale scores range from 1-5 with a higher score indicating higher medication collaboration between caregiver and patient.
Measured: 1 Month
Medication adherence
Self-reported medication adherence via the Medication Adherence Scale. Responses are summed and averaged, with total scores ranging from 0-5, and higher scores indicating better adherence.
Measured: 1 Month
Beliefs about dementia
Beliefs about dementia will be measured using the Representations and Adjustment to Dementia Index (RADIX) questionnaire. Individual items are scored, and scores range from 1-4.
Measured: 1 month
Medication Administration Hassles
Caregiver reported medication administration hassles will be measured using The Family Caregiver Medication Administration Hassles Scale. We will use the Logistics subscale. The total score ranges from 0-35, with higher scores indicating greater perceived hassle associated with managing the logistics of another person's medication regimen
Measured: 1 Month
Beliefs about independence with medicines
Beliefs about independence with medicines will be self reported using individual items. We will use report the frequency of agreement with individual items, where greater agreements indicates stronger beliefs in the importance of medication autonomy and independence.
Measured: 1 month
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted3 Aug 2026
- Study start3 Aug 2026
- Primary completionDec 2026 (estimated)
- Study completionDec 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Dementia Family CaregiverStudies of the same condition, open and under way.
- More trials run by Northwestern UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 30 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Northwestern University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Rachel O'Conor, Northwestern University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07742189
- Sponsor's protocol ID
- STU00226320
- Status last verified
- Aug 2026
- First submitted
- 27 Jul 2026
- Last updated
- 14 Aug 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 14 Aug 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Feasibility Study of a Brief Intervention to Support Medication Collaboration Among Older Adults and Family Care Partners
- ClinicalTrials.gov ID
- NCT07742189
- Acronym / sponsor ID
- STU00226320
- Conditions
- Dementia Family Caregiver, Dementia, Medication Adherence
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 30 participants (estimated)
- Lead sponsor
- Northwestern UniversityUniversity, hospital or other
- Study start
- 3 Aug 2026 (actual)
- Primary completion
- Dec 2026 (estimated)
- Study completion
- Dec 2026 (estimated)
- First posted
- 3 Aug 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study examines the feasibility and acceptability of a brief medication collaboration intervention among older adults (age 60+) with early-stage dementia or mild cognitive impairment who take multiple medications and their family caregivers. The main aims are to: 1) determine the feasibility and acceptability of the intervention for older adults with early-stage dementia and their family caregivers, and 2) explore the effects of intervention on medication collaboration, medication adherence, and beliefs about dementia and autonomy.
In this study, participants will: 1) complete a 15-30-minute baseline interview (by Zoom or phone), 2) participate together in a 45-60-minute virtual intervention led by an interventionist that includes:
Assessment of medication responsibilities and beliefs. Education about dementia and medication management. Cognitive restructuring to address beliefs about independence and caregiver assistance.
Collaborative planning for medication responsibilities and routines; and lastly 3) complete a 15-20-minute one-month follow-up interview (by Zoom or phone) to assess the intervention's acceptability and changes in medication management outcomes.
Study design
- Primary purpose
- Supportive care
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Medication Collaboration Intervention | Experimental | Behavioral: Medication Collaboration InterventionParticipants receive a brief virtual medication collaboration intervention designed to support collaborative medication management among older adults with early-stage dementia and their family caregivers. The intervention includes an assessment of medication responsibilities and beliefs, dementia and medication management education, reframing beliefs about autonomy and caregiver assistance, and collaborative development of medication management plans and action planning by setting implementation intentions. |
Who may qualify
- Ages
- 60 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (10 listed)
- Age 60 or older
- Diagnosis of dementia, Alzhimer's Disease or Mild Cognitive Impairment
- Quick Dementia Rating Scale Score 2-12 (inclusive of mild cognitive impairment and mild dementia)
- Taking 3 or more medications
- Involved with managing their medications
Key exclusion criteria (1 listed)
- adults unable to consent
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Medication Collaboration InterventionA brief virtual behavioral intervention for older adults with early-stage dementia and their family caregivers designed to support collaborative medication management. The intervention includes: (1) assessment of beliefs about dementia, autonomy, and current medication responsibilities; (2) education on dementia progression and medication management; (3) reframing maladaptive beliefs regarding independence and caregiver assistance; and (4) collaborative development of implementation intentions and medication responsibility plans to facilitate medication adherence and the transition of medication management responsibilities. The intervention is delivered remotely via Zoom or telephone in a single 45-60-minute session by trained study interventionists. | Behavioural | Medication Collaboration Intervention |
Primary outcome
Acceptability of the Medication Collaboration Intervention
Time frame: 1 Month
Participant-reported acceptability of the intervention will be measured using The Acceptability of Intervention Measure, Intervention Appropriateness Measure, and Feasibility of Intervention Measure. Scale values range from 1 to 5 with a higher score indicating greater perceived acceptability of the Medication Collaboration Intervention.
5 secondary outcomes
Medication Collaboration
Time frame: 1 Month
Medication adherence
Time frame: 1 Month
Beliefs about dementia
Time frame: 1 month
Medication Administration Hassles
Time frame: 1 Month
Beliefs about independence with medicines
Time frame: 1 month
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 14 Aug 2026.
- Individual participant dataSharing planned: No
Related trials for Dementia Family Caregiver
Not yet recruiting
Negotiation Training for Family Caregivers of People With Alzheimer's Disease
Alzheimer's Disease (AD), Dementia
Recruiting
The WeACT Program for Family Caregivers of People Living With Dementia
Depression, Caregivers
Recruiting
Feasibility and Acceptability of an LLM-based Chatbot for Family Caregivers: Evaluation Study
Caregivers
Not yet recruitingPhase 2
Peer Support for Family Caregivers of Older Adults Living With Dementia
Caregiver Burden, Caregiver Burnout
Active, not recruiting
Mindfulness-based Movement Therapy for Persons With Dementia and Family Caregivers
Dementia Caregiver
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Medication Collaboration Intervention in people with Dementia Family Caregiver and Dementia, run by Northwestern University at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 10 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 14 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Rachel O'Conor (13125033240, r-oconor@northwestern.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Acceptability of the Medication Collaboration Intervention (time frame: 1 Month). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Aug 2026.